Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective bet...
Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans
About this item
Full title
Author / Creator
C Weyer , P A Tataranni , S Snitker , E Danforth, Jr and E Ravussin
Publisher
United States: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist
in humans.
C Weyer ,
P A Tataranni ,
S Snitker ,
E Danforth, Jr and
E Ravussin
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes...
Alternative Titles
Full title
Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_highwire_diabetes_diabetes_47_10_1555
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_highwire_diabetes_diabetes_47_10_1555
Other Identifiers
ISSN
0012-1797
E-ISSN
1939-327X
DOI
10.2337/diabetes.47.10.1555
